Roger Flores‐Costa

809 total citations
19 papers, 581 citations indexed

About

Roger Flores‐Costa is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Roger Flores‐Costa has authored 19 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in Roger Flores‐Costa's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (9 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Roger Flores‐Costa is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (9 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Roger Flores‐Costa collaborates with scholars based in Spain, France and United States. Roger Flores‐Costa's co-authors include Cristina López‐Vicario, Joan Clària, Esther Titos, Marta Duran‐Güell, José Alcaraz‐Quiles, Mireia Casulleras, Bibiana Rius, Vicente Arroyo, Aritz Lopategi and Juan José Lozano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and The FASEB Journal.

In The Last Decade

Roger Flores‐Costa

18 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Flores‐Costa Spain 13 264 168 159 101 87 19 581
Marta Duran‐Güell Spain 14 271 1.0× 151 0.9× 166 1.0× 94 0.9× 80 0.9× 20 558
Mireia Casulleras Spain 15 352 1.3× 199 1.2× 254 1.6× 116 1.1× 81 0.9× 22 742
Karen M. Kassel United States 15 369 1.4× 268 1.6× 142 0.9× 113 1.1× 24 0.3× 20 800
Natalia Nuño‐Lámbarri Mexico 17 408 1.5× 275 1.6× 153 1.0× 106 1.0× 49 0.6× 46 815
David Orr New Zealand 10 252 1.0× 241 1.4× 214 1.3× 150 1.5× 60 0.7× 15 647
Elisa Mottaran Italy 10 347 1.3× 132 0.8× 131 0.8× 46 0.5× 35 0.4× 12 614
Song Lu China 16 275 1.0× 128 0.8× 69 0.4× 136 1.3× 51 0.6× 23 662
Benita L. McVicker United States 18 277 1.0× 216 1.3× 87 0.5× 73 0.7× 20 0.2× 50 788
Akitoshi Douhara Japan 14 353 1.3× 154 0.9× 209 1.3× 125 1.2× 28 0.3× 25 653

Countries citing papers authored by Roger Flores‐Costa

Since Specialization
Citations

This map shows the geographic impact of Roger Flores‐Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Flores‐Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Flores‐Costa more than expected).

Fields of papers citing papers by Roger Flores‐Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Flores‐Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Flores‐Costa. The network helps show where Roger Flores‐Costa may publish in the future.

Co-authorship network of co-authors of Roger Flores‐Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Flores‐Costa. A scholar is included among the top collaborators of Roger Flores‐Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Flores‐Costa. Roger Flores‐Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Flores‐Costa, Roger, Marta Duran‐Güell, Frank Erhard Uschner, et al.. (2025). An optimized peritonitis-induced ACLF model that reproduces the full spectrum of extrahepatic organ failures in mice. Hepatology Communications. 9(7).
2.
Zhang, Ingrid W., Cristina López‐Vicario, Mireia Casulleras, et al.. (2024). Palmitoylcarnitine impairs immunity in decompensated cirrhosis. JHEP Reports. 6(11). 101187–101187. 3 indexed citations
3.
Duran‐Güell, Marta, Glòria Garrabou, Roger Flores‐Costa, et al.. (2023). Essential role for albumin in preserving liver cells from TNFα‐induced mitochondrial injury. The FASEB Journal. 37(3). e22817–e22817. 14 indexed citations
4.
López‐Vicario, Cristina, David Sebastián, Mireia Casulleras, et al.. (2022). Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease. Hepatology. 77(4). 1303–1318. 19 indexed citations
5.
López‐Vicario, Cristina, Noelia Pérez, Mireia Casulleras, et al.. (2022). Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells. International Journal of Obesity. 46(11). 1960–1969. 24 indexed citations
6.
Casulleras, Mireia, Roger Flores‐Costa, Marta Duran‐Güell, et al.. (2022). Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution. Hepatology Communications. 6(6). 1443–1456. 9 indexed citations
7.
Clària, Joan, Roger Flores‐Costa, Marta Duran‐Güell, & Cristina López‐Vicario. (2021). Proresolving lipid mediators and liver disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(11). 159023–159023. 13 indexed citations
8.
Duran‐Güell, Marta, Roger Flores‐Costa, Mireia Casulleras, et al.. (2021). Albumin protects the liver from tumor necrosis factor α‐induced immunopathology. The FASEB Journal. 35(2). e21365–e21365. 36 indexed citations
9.
Zhang, Ingrid W., Anna Curto, Cristina López‐Vicario, et al.. (2021). Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure. Journal of Hepatology. 76(1). 93–106. 66 indexed citations
10.
Flores‐Costa, Roger, Marta Duran‐Güell, Mireia Casulleras, et al.. (2020). Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit. Proceedings of the National Academy of Sciences. 117(45). 28263–28274. 45 indexed citations
11.
Casulleras, Mireia, Roger Flores‐Costa, Marta Duran‐Güell, et al.. (2020). Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis. Science Translational Medicine. 12(566). 53 indexed citations
12.
Flores‐Costa, Roger, Marta Duran‐Güell, Mireia Casulleras, et al.. (2019). FRI-296-Interaction between the soluble guanylate cyclase and the NLRP3 inflammasome in Kupffer cells: Implications for the anti-inflammatory actions of sGC stimulation in liver. Journal of Hepatology. 70(1). e525–e525. 1 indexed citations
13.
López‐Vicario, Cristina, Esther Titos, Mary E. Walker, et al.. (2019). Leukocytes from obese individuals exhibit an impaired SPM signature. The FASEB Journal. 33(6). 7072–7083. 49 indexed citations
14.
Casulleras, Mireia, José Alcaraz‐Quiles, Marta Duran‐Güell, et al.. (2019). FRI-111-Albumin modulates endosomal TLR9 signaling in human peripheral leukocytes: A mechanism for its anti-inflammatory role in ACLF. Journal of Hepatology. 70(1). e436–e436. 2 indexed citations
15.
Alcaraz‐Quiles, José, Mireia Casulleras, Karl Oettl, et al.. (2018). Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen‐Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis. Hepatology. 68(5). 1937–1952. 63 indexed citations
16.
Lopategi, Aritz, Roger Flores‐Costa, Bibiana Rius, et al.. (2018). Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome. Journal of Leukocyte Biology. 105(1). 25–36. 69 indexed citations
17.
Flores‐Costa, Roger, José Alcaraz‐Quiles, Esther Titos, et al.. (2017). The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis. British Journal of Pharmacology. 175(6). 953–967. 53 indexed citations
18.
Rius, Bibiana, Marta Duran‐Güell, Roger Flores‐Costa, et al.. (2017). The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia‐induced endoplasmic reticulum stress. The FASEB Journal. 31(12). 5384–5398. 58 indexed citations
19.
Flores‐Costa, Roger, José Alcaraz‐Quiles, Esther Titos, et al.. (2017). The soluble guanylate cyclase stimulator IW-1973 prevents inflammation and fibrosis in experimental non-alcoholic steatohepatitis. Journal of Hepatology. 66(1). S17–S17. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Duran‐Güell Breakdown of academic impact, for papers by Mireia Casulleras Breakdown of academic impact, for papers by Karen M. Kassel Breakdown of academic impact, for papers by Natalia Nuño‐Lámbarri Breakdown of academic impact, for papers by David Orr Breakdown of academic impact, for papers by Elisa Mottaran Breakdown of academic impact, for papers by Song Lu Breakdown of academic impact, for papers by Benita L. McVicker Breakdown of academic impact, for papers by Akitoshi Douhara
Rankless by CCL
2026